Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD

Consultant Medical Oncology

acfziy@r.postjobfree.com

Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD

Consultant Clinical Oncology

**** ***** ****, ****** **rks, NS, Canada

acfziy@r.postjobfree.com

+1-902-***-****

Degrees

Cairo University – Kasr Al Aini Medical School, Cairo University

Medical Doctorate Degree MD (PhD equivalent)

in Radiotherapy( Medical Oncology& Radiation Oncology ) Nov 2004

Master Degree MSc in Radiotherapy Nov 1984

Bachelor in Medicine & Surgery MB,BCh Dec 1978

Clinical Experience

Saudi Arabia Ministry of Health from Aug 2006 – to Oct 2013

Oct 2011 – Oct 2013

Associate Consultant Medical Oncology -Jeddah Oncology Center -King Abdul Allah Medical City

Oct 2009 – Sept 2011

Associate Consultant Medical Oncology - Oncology Center - King Abdul Aziz Hospital

Aug 2006 – Sept 2009

Specialist Medical Oncology - Oncology Center - King Abdul Aziz Hospital

Egypt April 1980 - July 2006

Worked at EAEA Egypt Atomic Energy Authority

April 2005 – July 2006

Lecturer Radiotherapy

March 1998 -March 2005

Assistant Lecturer Radiotherapy

Nov 1984 – Nov 1985

Specialist Radiotherapy

April 1980 – Oct 1984

Registrar

March 1979 –March 1980

House officer in Cairo University Hospitals (2000 beds)

Nov 1981- Nov 1983

Resident in Clinical Oncology Department Cairo University Teaching Hospital

KSA Dec 1985 – Nov 1997

Specialist Radiation Oncology – Dr. Ghassan N Pharaon Hospital

1

Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD

Consultant Medical Oncology

acfziy@r.postjobfree.com

Duties

• Examination of cancer patients, either as new referral or follow up patients

• Ordering the necessary investigations for staging workup and routine follow up

• Prescribing non-surgical treatment in the form of chemotherapy, hormonal or biological therapy for

inpatients and outpatients

• Participating in multidisciplinary clinics

• Clinical rounds for the inpatients

• Consultation for referral from other consultants in different specialties.

• Sharing in the rotation for consultants on call

• Designing and sharing in research work

• Sharing in the training program of residents in Oncology Center

• Vice president of scientific committee for Continuous Medical Education in Oncology Center

Research Experience:

Member of Gulf Oncology Research Group (GORG) since May 2008

Contributed as co-invetigator in:

GORG 001 Study “A multicenter Prospective Phase II Trial of Neo-adjuvant (FEC 100) Cisplatin

Docetaxel + Trastuzumab in women who overexpressed or amplified Her2/neu with locally advanced

Breast Cancer” 2010

GORG 002 Study “Randomized Phase III study to determine the effectiveness of Vitamin D2

(Ergocalciferol) given with Docetaxel versus Docetaxel in Patients with Metastatic Breast Cancer”

2011

Study ML18147 “A randomized, open-label phase III Intergroup study: Effect of adding bevacizumab

to cross over fluoropyrimidine-based chemotherapy (CTx) in patients with metastatic colorectal cancer

and disease progression under first-line standard CTx / bevacizumab combination”. July2009-2011

Also shared as coauthor in the study “Lapatinib-based therapy for women with advanced/metastatic

HER2+ breast cancer”.,ASCO 2014, abstract.

Author of -“Assessment of Clinical and Pathological Response of Locally Advanced Breast Cancer to

Upfront Triplet Combination Chemotherapy” (Docetaxel, Epirubicin and Cyclophosphamide),

Cairo Univ.J. Sept., 2008 (abstract form in BMJ (Middle East)

PhD Thesis -"A Study of the Relationship between Biological Markers and Radioresistance and

Chemoresistance in Squamous Cell Carcinoma of Head and Neck" an M.D. Thesis, Cairo Univ.,

2001

M.S.Thesis "Clinicoepidemiological Study of Oropharyngeal Carcinoma" A M.Sc. Thesis, Cairo

University,

1982.

I have experience in designing clinical trials protocols and CRF as well as scientific writing,

Licenses

Valid license as consultant oncologist in KSA till Apr 2016

License of Egyptian Syndicate for Physicians.

2

Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD

Consultant Medical Oncology

acfziy@r.postjobfree.com

Applied for defined license in NS, Canada

Member of

General Syndicate for Physician in Egypt since 1980

Egypt Cancer Society

Saudi Cancer Society

Training Courses & Workshops

* Abdominal Ultrasonography for physicians

Obstetrics and Gynecology Ultrasonography for Physicians

Cairo University Hospitals - Nov 1986

*Multidisciplinary Course in Mammography

North West National Training Centre UK - Mar 1996

*Practical Training clinical attachment

North West National Training Centre, Manchester UK - Mar 1995

*Fellow of Baltimore University Hospital, MD USA - Sep 1997

*Application of Immunohistochemistry

Eye Research Centre, Cairo - Sep 1998

*Medical Treatment of Radiation Accidents"

Arab Atomic Energy Authority, Cairo - Nov 1999

*Cell Culture & Bioreactor Technology

Egyptian Atomic Energy Authority, Cairo – Oct 2001

*NIH Clinical Research Training Online Course 2011

Conferences Symposia & Workshops

ECCO ESMO Amsterdam Sep 2013

June 2012 ASCO in Chicago, IL USA

March 2012 Women Cancer Conference in Austin, TX USA

Dec 2011 Breast Cancer Conference in San Antonio, TX USA

Nov 2010 Annual Conference of British National Cancer Research Institute in Liverpool, UK

Nov 2009 Annual Conference of British National Cancer Research Institute in Birmingham, UK

{Poster presentation}

March 2009 Breast Cancer Conference in St.Gallen, Switzerland

3

Dr.Mohamed Mokhtar Ibrahim MB BCh, MSc, MD

Consultant Medical Oncology

acfziy@r.postjobfree.com

Publications&Clinical Trials

1- "Clinicoepidemiological Study of Oropharyngeal Carcinoma" A M.Sc. Thesis, Cairo University,

1982.

2-"Role of Adjuvant Systemic Therapy in the Management of Breast Cancer", J.Egypt Nat.Can.Inst.

Vol.5, No3:605, 1992

3-"A Study of the Relationship between Biological Markers and Radioresistance and

Chemoresistance in Squamous Cell Carcinoma of Head and Neck" an M.D. Thesis, Cairo Univ.,

2001

4-“Assessment of Clinical and Pathological Response of Locally Advanced Breast Cancer to Upfront

Triplet Combination Chemotherapy” (Docetaxel, Epirubicin and Cyclophosphamide),

Cairo Univ.J. Sept., 2008 (abstract form in BMJ (Middle East)

5-Case Report: “Premenopausal Patient with HER2+ Metastatic Breast Cancer Treated with Lapatinib

And Capcitabine” The Oncologist Aug 2010, 68

6- “Lapatinib-based therapy for women with advanced/metastatic HER2+ breast cancer”.,ASCO 2014, abstract.

7- Co-investigator in A multicenter prospective Phase II trial of neo-adjuvant (FEC 100)/Cisplatin- Docetaxel with or

without Trastuzumab in locally advanced breast cancer. Gulf Oncology Research Group (GORG-001).

7- Co-investigator in A randomized, open-label phase III Intergroup study: Effect of adding bevacizumab to cross

over fluoropyrimidine-based chemotherapy (CTx) in patients with metastatic colorectal cancer and disease

progression under first-linestandard CTx / bevacizumab combination. July 2010

8-Co-investigator in Vit D3 study Randomized phase III trial to determine the effectiveness of Vitamin D2

(Ergocalciferol) given with Docetaxel versus Docetaxel in patients with metastatic breast cancer.

References:

Available upon request

4

Contact this candidate